Mucin glycoprotein backbone (MUC)

The mucin glycoprotein backbone, also known as the apomucin, is the central polypeptide chain of mucins, which are large, heavily O-glycosylated proteins found on epithelial surfaces (UniProt, P15941). These proteins play a critical role in forming a protective physical barrier, lubricating tissues, and participating in cell signaling pathways (PubMed, 22235255). In healthy tissues, the protein backbone is extensively covered by complex carbohydrate chains; however, in many cancers, glycosylation is truncated, exposing the underlying protein core (Nat Rev Cancer, 2004). This exposure makes the mucin backbone a significant therapeutic target for monoclonal antibodies and cancer vaccines, particularly for MUC1 and MUC16 (PubMed, 29945662). Additionally, in respiratory and gastrointestinal diseases, the overproduction or altered structure of the mucin backbone contributes to pathology, making it a target for mucolytic agents that modify its physical properties (StatPearls, Acetylcysteine). Understanding the structural integrity and modification of the mucin backbone is essential for developing treatments for adenocarcinoma and chronic inflammatory conditions.

Other names

ApomucinMucin protein coreMucin polypeptideMucin protein backbone

Mucolytic agents reduce the viscosity of mucus by cleaving disulfide bonds within the mucin backbone or its cross-links (StatPearls, Acetylcysteine). In oncology, monoclonal antibodies and vaccines target specific epitopes on the aberrantly glycosylated mucin protein core to induce antibody-dependent cellular cytotoxicity (ADCC) or T-cell mediated immune responses (Nat Rev Cancer, 2004).